Author

Sydney S. Wilbon

Observed names: SYDNEY S. WILBON, SYDNEY WILBON, Sydney Symone Wilbon

Observed institutions: University of Miami, University of Miami Health System, Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, The University of Texas Health Science Center at Houston

OpenAlex ID: A5036089137

GLP1 Receptor Agonists—Effects beyond Obesity and Diabetes

2023 · Sydney S. Wilbon, Mikhail G. Kolonin · Cells · 99

Sterol-O-acyltransferase-1 has a role in kidney disease associated with diabetes and Alport syndrome

2020 · Xiaochen Liu, Gloria Michelle Ducasa, et al. · Kidney International · 58

Discoidin domain receptor 1 activation links extracellular matrix to podocyte lipotoxicity in Alport syndrome

2020 · Jin-Ju Kim, Judith M. David, et al. · EBioMedicine · 54

Podocyte Lipotoxicity in CKD

2021 · Jin-Ju Kim, Sydney S. Wilbon, et al. · Kidney360 · 34

3057-LB: GLP-1 Receptor Agonist Treatment Promotes IL6-Dependent Activation of Brown Adipogenesis Program and Glucose Uptake in Adipose Tissue of Insulin-Resistant Humans

2026 · ABSALON D. GUTIERREZ, ZHANGUO GAO, et al. · Diabetes

Corrigendum to “Discoidin domain receptor 1 activation links extracellular matrix to podocyte lipotoxicity in Alport syndrome” eBioMedicine, Volume 63, January 2021, 103162

2025 · Jin-Ju Kim, Judith M. David, et al. · EBioMedicine

1678-P: Weight-Independent GLP-1RA Effects on Adipose Tissue PGC1-α and TERT in Insulin-Resistant Humans

2025 · ABSALON D. GUTIERREZ, JR.__ZHANGUO GAO, et al. · Diabetes

Plin5 Deficiency in Podocyte Negatively Affects the Communication Between Lipid Droplets and Mitochondria in Alport Syndrome

2021 · Jin Ju Kim, Sydney S. Wilbon, et al. · Journal of the American Society of Nephrology

Role of Plin5 Deficiency in Podocyte Lipotoxicity and the Progression of Alport Syndrome

2020 · Jin Ju Kim, Sydney S. Wilbon, et al. · Journal of the American Society of Nephrology

Works count: 9

Citation count: 245

H-index: 4

I10-index: 4